On September 22, 2022, the U.S. Patent and Trademark Office (USPTO) conducted a live meeting for its Artificial Intelligence (AI) and Emerging Technologies (ET) Partnership Series. During this meeting, panelists from industry and the USPTO provided helpful tips on drafting and prosecuting patent applications that include AI components, including special tips for the biotech industry. Key takeaways from the meeting and published materials will be summarized in our Three-Part Blog Series.
About
Jesse Salen is an associate in the Intellectual Property Practice Group in the firm's San Diego (Del Mar) office.
Latest Post
More Posts
Takeaways From the U.S. Patent and Trademark Office’s Artificial Intelligence and Emerging Technologies Partnership Series – Part One of Three
Healthcare Res. Mgmt. Grp., LLC v. Econatura All Healthy World, LLC – A Cautionary Tale: Meticulous or Careless Strategy Required to Prove Your Trade Secret Claim
Federal Circuit Agrees to Reconsider Ruling in GSK v. Teva Drug Patent Case
Patient Empowerment Through Technology is Focus of ENGAGE Conference
UPDATE: The Federal Defend Trade Secrets Act vs. The California Uniform Trade Secrets Act
UPDATE: The Federal Defend Trade Secrets Act vs. The California Uniform Trade Secrets Act
The Federal Defend Trade Secrets Act vs. The California Uniform Trade Secrets Act
Extending the Patentable Life of 3D Printers: A Lesson From the Pharmaceutical Industry
Extending the Patentable Life of 3D Printers: A Lesson From the Pharmaceutical Industry
U.S. Patent and Trademark Office Clarifies “Patent Eligible Subject” Matter in its Recent Guidance in Light of Alice
About
Jesse Salen is an associate in the Intellectual Property Practice Group in the firm's San Diego (Del Mar) office.
Connect: http://www.sheppardmullin.com/jsalen
Subscribe: Subscribe via RSS